diabetic-foot-ulcer
(2)
Empo Health
Empo Health makes diabetic foot ulcer detection as easy as stepping on a bathroom scale. The Empo Footprint imaging scale captures high-resolution images of patients' feet at home and sends them to clinicians through the HIPAA-compliant Empo Remote Health Link, catching ulcers before they become amputations.
Anuj Khandelwal
Anuj Khandelwal is the CEO and Co-Founder of Empo Health, a San Bruno, CA-based medical device company developing in-home monitoring systems to prevent diabetic foot amputations. With a BS in Mechanical Engineering from MIT and MS in Mechanical Engineering (Medical Devices) from Stanford, Khandelwal founded Empo Health in 2020 alongside co-founder Eric Dahlseng. The company's flagship product — Empo Footprint, an FDA-listed in-home imaging scale — lets diabetic patients monitor foot health from home, transmitting images to care teams for early intervention. In June 2025, Empo Health raised a $7 million round led by Story Ventures to commercialize its remote diabetic foot ulcer management system.